ADC Therapeutics' Corporate Minority Round

ADC Therapeutics raised a round of funding on October 16, 2013. Investors include MedImmune.

ADC Therapeutics (ADCT) is an oncology drug development company that specializes in the development of proprietary Antibody Drug Conjugates (ADCs) targeting major solid and hematological cancers. The …

Articles about ADC Therapeutics' Corporate Minority Round: